Department of Clinical Laboratory, Renmin Hospital of Wuhan University, Wuhan, Hubei, China (mainland).
Med Sci Monit. 2019 Oct 29;25:8112-8119. doi: 10.12659/MSM.917000.
BACKGROUND The objective of our research was to assess the possible link between diabetes mellitus (DM) and liver cirrhosis in chronic hepatitis B (CHB) patients in Wuhan, China. MATERIAL AND METHODS Individuals with a diagnosis of both liver cirrhosis and chronic HBV infection (n=257), and CHB-only patients (n=514) were matched 1: 2 by age and sex. Demographic, lifestyle, laboratory, and clinical characteristics were reviewed. Univariate and the multiple logistic regression analysis were conducted to investigate the association between DM and HBV-related liver cirrhosis. RESULTS The prevalence of DM was higher among CHB patients with liver cirrhosis than in those without liver cirrhosis (22.2% vs. 12.8%, P=0.001), yielding an adjusted odds ratio (AOR) of 2.317 and a 95% confidence interval (CI) of 1.528-3.513. Among them, 87.7% of liver cirrhosis patients were diagnosed with DM before liver cirrhosis diagnosis, yielding an AOR (95% CI) of 2.386 (1.533-3.714). In comparison to patients with a DM duration of 2-5 years, the AOR (95% CI) for those with a DM duration >5 years was 2.073 (0.701-6.132). In DM treatment, the AOR (95% CI) for those treated with insulin was 4.746 (1.329-16.949). CONCLUSIONS DM was associated with cirrhosis risk in CHB patients in Wuhan, China.
本研究旨在评估中国武汉地区慢性乙型肝炎(CHB)患者中糖尿病(DM)与肝硬化之间的可能关联。
我们将 257 例同时诊断为肝硬化和慢性 HBV 感染的患者与 514 例 CHB 患者进行 1:2 年龄和性别匹配。回顾了人口统计学、生活方式、实验室和临床特征。采用单因素和多因素逻辑回归分析来探讨 DM 与 HBV 相关肝硬化之间的关系。
与无肝硬化的 CHB 患者相比,患有肝硬化的 CHB 患者中 DM 的患病率更高(22.2%比 12.8%,P=0.001),调整后的优势比(AOR)为 2.317,95%置信区间(CI)为 1.528-3.513。其中,87.7%的肝硬化患者在肝硬化诊断前被诊断为 DM,AOR(95%CI)为 2.386(1.533-3.714)。与 DM 病程 2-5 年的患者相比,DM 病程>5 年的患者 AOR(95%CI)为 2.073(0.701-6.132)。在 DM 治疗中,使用胰岛素治疗的患者 AOR(95%CI)为 4.746(1.329-16.949)。
DM 与中国武汉地区 CHB 患者的肝硬化风险相关。